Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma

    Tag: pharma

    You Searched For "pharma"
    Pfizer gets USFDA nod for biosimilar to Rituximab

    Pfizer gets USFDA nod for biosimilar to Rituximab

    Medical Dialogues Bureau25 July 2019 8:59 AM IST
    Ruxience is a mAb biosimilar to Rituxan which works by targeting a protein called CD20, which is present on the surface of B cells. Ruxience is...
    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    Medical Dialogues Bureau24 July 2019 12:16 PM IST
    NPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs 5.56 crore has been...
    Torrent Pharma Q1 net profit up 33 percent to Rs 216 crore

    Torrent Pharma Q1 net profit up 33 percent to Rs 216 crore

    Medical Dialogues Bureau24 July 2019 9:30 AM IST
    The firm's India business was up nine per cent year-on-year to Rs 907 crore for the quarter. The US revenues at Rs 376 crore were up by 13 per cent...
    Sanofi strikes deal for US rights to Roche Tamiflu

    Sanofi strikes deal for US rights to Roche Tamiflu

    Medical Dialogues Bureau24 July 2019 9:15 AM IST
    Under the terms of the agreement, Sanofi will be responsible for leading FDA negotiations for the OTC switch and subsequent exclusive marketing,...
    Doctors should prescribe only generic medicines: CDSCO Committee

    Doctors should prescribe only generic medicines: CDSCO Committee

    Medical Dialogues Bureau23 July 2019 5:36 PM IST
    The generic medicines are at least 90 per cent cheaper than branded medicines. There are nearly 600 types of generic medicines and about 23 kinds of...
    Laurus Labs, Rising Pharma launches neuropathic pain capsules in US

    Laurus Labs, Rising Pharma launches neuropathic pain capsules in US

    Medical Dialogues Bureau23 July 2019 9:30 AM IST
    Rising Pharmaceuticals has launched a generic version of Lyrica capsules, in the strengths of 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and...
    Gilead licenses respiratory, herpes antiviral research programs from Novartis

    Gilead licenses respiratory, herpes antiviral research programs from Novartis

    Medical Dialogues Bureau23 July 2019 9:15 AM IST
    Under the agreement, Gilead will acquire exclusive global rights to develop and commercialize novel small molecules against three undisclosed targets....
    Delhi HC restricts Lee Pharma from infringing copyright of Mankind Pharma

    Delhi HC restricts Lee Pharma from infringing copyright of Mankind Pharma

    Medical Dialogues Bureau21 July 2019 4:30 PM IST
    Justice Prathiba M Singh said considering the evidence and the content of the website of Lee Pharmaceuticals of Lee House being identical, a permanent...
    Zydus Cadila arm gets USFDA nod for generic version of Adderall XR capsules in US

    Zydus Cadila arm gets USFDA nod for generic version of Adderall XR capsules in US

    Medical Dialogues Bureau21 July 2019 10:00 AM IST
    The product is a generic version of Adderall XR capsules and will be manufactured at Nesher Pharmaceuticals' manufacturing facility at St Louis in the...
    USFDA to review Sanofi isatuximab for treatment of multiple myeloma

    USFDA to review Sanofi isatuximab for treatment of multiple myeloma

    Medical Dialogues Bureau21 July 2019 9:15 AM IST
    Sanofi Isatuximab targets a specific epitope on the CD38 receptor. It is designed to trigger multiple, distinct mechanisms of action that are believed...
    Strides Pharma found destroying, dumping drug production documents: USFDA Investigation

    Strides Pharma found destroying, dumping drug production documents: USFDA Investigation

    Medical Dialogues Bureau20 July 2019 2:16 PM IST
    In the letter to Strides Pharma, the FDA didn't explain whether its inspectors often check scrap yards or shredding rooms for documents, or whether it...
    Dr Reddys unveils generic version of Allegra D in US to treat common cold, flu

    Dr Reddys unveils generic version of Allegra D in US to treat common cold, flu

    Medical Dialogues Bureau20 July 2019 11:37 AM IST
    In a BSE filing, Dr Reddy's Labs(Dr Reddys) announced "launch of Fexofenadine HCI 60 mg and Pseudoephedrine HCI 120 mg extended-release tablets, USP,...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok